Firmament made an investment in the Company alongside McLean Family Farms (“MFF”) and Sweat Equities, LLC (“SE”).
A digital, educational platform and events company created by families for families.
Nautilus Biotechnology has raised $76 million to help find ways to treat diseases like cancer and multiple sclerosis.
Former IQ-EQ, Citco fund services veteran joins up with Dutch-headquartered fund administrator.
Tourmaline Partners, a trading solution for hedge funds and asset managers, formally announced it received a majority investment from Copley Equity Partners. The development comes alongside Tourmaline’s existing technology and human capital initiatives which provide clients access to unparalleled liquidity, market intelligence, customized workflows, and best execution.
Building your business requires new clients – we all know that. But, how do you find those clients? One of the largest challenges any advisor faces, whether new or experienced, is building and maintaining a prospect list. The standard suggestions on how to do this aren’t bad—many, if not most, advisors succeed using standard practices—but I have found a few tweaks that make the standard suggestions more efficient.
The COVID-19 pandemic might have decimated portfolio values around the world, but that didn’t stop bankers to the ultra-rich from turning a tidy profit.
Succession planning no doubt involves asking and answering some difficult questions; especially for the head of the family or chairperson of the business.
The U.K.-headquartered bank will place a much greater focus on the family office segment in Asia following the new merger of its wealth unit.
With the benefit of hindsight, that turned out to be about right. Oxford Lane Capital Corp., a fund flagged by Barron’s that traded at $10.53 in July 2018, would top out at $11.50 a month later. It’s now worth just $3, not far from its low in March. Eagle Point Credit Co., which traded at $18.65 at the time, would climb by less than a dollar over the following year and is now hovering around $5.75. While these investments are known for their high yields, that’s still a steep loss in total value. And unlike public equities and even high-yield bonds, the funds show little evidence of rebounding anytime soon.
